Literature DB >> 29054358

A comparative study of warheads for design of cysteine protease inhibitors.

Daniel G Silva1, Jean F R Ribeiro1, Daniela De Vita1, Lorenzo Cianni1, Caio Haddad Franco2, Lucio H Freitas-Junior2, Carolina Borsoi Moraes2, Josmar R Rocha1, Antonio C B Burtoloso3, Peter W Kenny4, Andrei Leitão5, Carlos A Montanari6.   

Abstract

The effects on potency of cruzain inhibition of replacing a nitrile group with alternative warheads were explored. The oxime was almost an order of magnitude more potent than the corresponding nitrile and has the potential to provide access to the prime side of the catalytic site. Dipeptide aldehydes and azadipeptide nitriles were found to be two orders of magnitude more potent cruzain inhibitors than the corresponding dipeptide nitriles although potency differences were modulated by substitution at P1 and P3. Replacement of the α methylene of a dipeptide aldehyde with cyclopropane led to a loss of potency of almost three orders of magnitude. The vinyl esters and amides that were characterized as reversible inhibitors were less potent than the corresponding nitrile by between one and two orders of magnitude.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aldehyde; Covalent inhibitor; Cysteine protease; Nitrile; Oxime; Warhead

Mesh:

Substances:

Year:  2017        PMID: 29054358     DOI: 10.1016/j.bmcl.2017.10.002

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  Catch and Anchor Approach To Combat Both Toxicity and Longevity of Botulinum Toxin A.

Authors:  Lucy Lin; Margaret E Olson; Takashi Sugane; Lewis D Turner; Margarita A Tararina; Alexander L Nielsen; Elbek K Kurbanov; Sabine Pellett; Eric A Johnson; Seth M Cohen; Karen N Allen; Kim D Janda
Journal:  J Med Chem       Date:  2020-09-18       Impact factor: 7.446

2.  On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors.

Authors:  Vinicius Bonatto; Pedro Henrique Jatai Batista; Lorenzo Cianni; Daniela De Vita; Daniel G Silva; Rodrigo Cedron; Daiane Y Tezuka; Sérgio de Albuquerque; Carolina Borsoi Moraes; Caio Haddad Franco; Jerônimo Lameira; Andrei Leitão; Carlos A Montanari
Journal:  RSC Med Chem       Date:  2020-09-09

3.  Mapping the S1 and S1' subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents.

Authors:  Lorenzo Cianni; Carina Lemke; Erik Gilberg; Christian Feldmann; Fabiana Rosini; Fernanda Dos Reis Rocho; Jean F R Ribeiro; Daiane Y Tezuka; Carla D Lopes; Sérgio de Albuquerque; Jürgen Bajorath; Stefan Laufer; Andrei Leitão; Michael Gütschow; Carlos A Montanari
Journal:  PLoS Negl Trop Dis       Date:  2020-03-12

Review 4.  Advances in developing small molecule SARS 3CLpro inhibitors as potential remedy for corona virus infection.

Authors:  Manashjyoti Konwar; Diganta Sarma
Journal:  Tetrahedron       Date:  2020-11-19       Impact factor: 2.457

Review 5.  Covalent Reversible Inhibitors of Cysteine Proteases Containing the Nitrile Warhead: Recent Advancement in the Field of Viral and Parasitic Diseases.

Authors:  Simone Brogi; Roberta Ibba; Sara Rossi; Stefania Butini; Vincenzo Calderone; Sandra Gemma; Giuseppe Campiani
Journal:  Molecules       Date:  2022-04-15       Impact factor: 4.927

Review 6.  The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizations.

Authors:  Ryan P Joyce; Vivian W Hu; Jun Wang
Journal:  Med Chem Res       Date:  2022-08-30       Impact factor: 2.351

7.  The Alkyne Moiety as a Latent Electrophile in Irreversible Covalent Small Molecule Inhibitors of Cathepsin K.

Authors:  Elma Mons; Ineke D C Jansen; Jure Loboda; Bjorn R van Doodewaerd; Jill Hermans; Martijn Verdoes; Constant A A van Boeckel; Peter A van Veelen; Boris Turk; Dusan Turk; Huib Ovaa
Journal:  J Am Chem Soc       Date:  2019-02-14       Impact factor: 15.419

8.  The nature of ligand efficiency.

Authors:  Peter W Kenny
Journal:  J Cheminform       Date:  2019-01-31       Impact factor: 5.514

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.